IP Library Granted Patent US 7,772,185
Granted Patent B2
US 7,772,185 · App. 11/051,996 · Granted Aug 10, 2010

Method for promoting axonal outgrowth in damaged nerves

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,772,185
App. No.
11/051,996
Granted
Aug 10, 2010
Kind
B2
Abstract

The subject invention pertains to the therapeutic use of certain GAG-degrading enzymes, and enzyme combinations, to promote nerve repair and regeneration.

Claims (16)

1. A method for promoting axonal outgrowth from a damaged nerve, wherein said method comprises applying at least one heparan sulfate proteoglycan-degrading enzyme to the damaged nerve, wherein the method comprises:

a) coapting proximal and distal stumps, of a severed nerve, either directly or through a nerve graft or conduit, and applying the enzyme to the severed nerve; or

b) applying the enzyme directly to a nerve that has been damaged but not completely severed; wherein the heparan sulfate proteoglycan-degrading enzyme is selected from the group consisting of heparinase I, heparinase III, and heparanase, and is applied to the damaged nerve at a concentration sufficient to cause axonal outgrowth.

2. The method, according to claim 1 , wherein said enzyme is heparinase I or heparinase III.

3. The method, according to claim 1 , wherein said enzyme is heparinase I.

4. The method, according to claim 1 , further comprising administering at least one other glycosaminoglycan (GAG)-degrading enzyme to the nerve.

5. The method, according to claim 1 , further comprising administering to the nerve at least one chondroitin sulfate proteoglycan-degrading enzyme selected from the group consisting of chondroitinase ABC, chondroitinase A, chondroitinase C, and chondroitinase AC.

6. The method, according to claim 1 , further comprising administering to the nerve at least one keratan sulfate proteoglycan-degrading enzyme.

7. The method, according to claim 6 , wherein said keratin sulfate proteoglycan-degrading enzyme is keratanase or endo-b-galactosidase.

8. The method according to claim 1 , wherein said method further comprises co-applying a tissue adhesive to the damaged nerve.

9. The method according to claim 1 , wherein said method further comprises applying a growth factor or trophic factor to the damaged nerve.

10. The method according to claim 1 , wherein the damaged nerve is a damaged peripheral nerve.

11. The method according to claim 1 , wherein the damaged nerve is a damaged central nerve.

12. The method according to claim 1 , wherein the damaged nerve is human.

13. A method for promoting axonal outgrowth from a severed nerve, wherein said method comprises coapting proximal and distal stumps of the severed nerve, either directly or through a nerve graft or conduit, and applying to the severed nerve a heparan sulfate proteoglycan-degrading enzyme selected from the group consisting of heparinase I, heparinase III, and heparanase, wherein said enzyme is applied to the nerve at a concentration sufficient to cause axonal outgrowth.

14. The method, according to claim 13 , wherein said enzyme is heparinase I.

Assignments (8)
RELEASE OF SECURITY INTEREST OF REEL/FRAME 034173/0187 Recorded Oct 27, 2016
From: THREE PEAKS CAPITAL S.A.R.L.
To: AXOGEN CORPORATION; AXOGEN, INC. (FORMERLY KNOWN AS LECTEC CORPORATION)
Reel/Frame 040502/0018 →
SECURITY INTEREST Recorded Nov 14, 2014
From: AXOGEN CORPORATION
To: THREE PEAKS CAPITAL S.A.R.L.
Reel/Frame 034173/0187 →
RELEASE OF SECURITY AGREEMENT Recorded Oct 5, 2012
From: MIDCAP FINANCIAL SBIC, LP
To: AXOGEN, INC.; AXOGEN CORPORATION
Reel/Frame 029087/0774 →
CONFIRMATORY LICENSE Recorded Nov 25, 2011
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027281/0912 →
CONFIRMATORY LICENSE Recorded Oct 5, 2011
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027018/0962 →
SECURITY AGREEMENT Recorded Sep 30, 2011
From: AXOGEN, INC.; AXOGEN CORPORATION
To: MIDCAP FINANCIAL SBIC, LP
Reel/Frame 027000/0770 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jul 18, 2008
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021260/0648 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2005
From: ENGLISH, ARTHUR W.; MCKEON, ROBERT; WERNER, ERICA
To: EMORY UNIVERSITY
Reel/Frame 016052/0309 →